Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Phathom Pharmaceuticals is a biopharmaceutical company.
Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.
Ambros Therapeutics is a clinical-stage biotechnology company.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Belite Bio is a clinical stage biopharmaceutical drug development company.
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
Sortera Alloys manufactures low-cost, high-quality metal alloys for domestic manufacturing using its artificial intelligence technology.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 15 different industry categories.
Among tracked funding rounds, Wave Life Sciences received $350.0M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Nautilus Biotechnology, BioAge Labs, Kinaset Therapeutics, Diagonal Therapeutics, Century Therapeutics. These companies were founded in 2020 or later.